WCM Investment Management Portfolio holdings
AUM
$43.8B
This Quarter Return
+12.31%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$28.5B
AUM Growth
+$28.5B
(+9.3%)
Cap. Flow
-$337M
Cap. Flow
% of AUM
-1.18%
Top 10 Holdings %
Top 10 Hldgs %
63.12%
Holding
188
New
8
Increased
132
Reduced
20
Closed
9
Top Buys
| 1 |
Aon
AON
|
$898M |
| 2 |
Amphenol
APH
|
$105M |
| 3 |
Sherwin-Williams
SHW
|
$101M |
| 4 |
TSMC
TSM
|
$94.9M |
| 5 |
Mercado Libre
MELI
|
$94.9M |
Top Sells
| 1 |
Shopify
SHOP
|
$1.46B |
| 2 |
lululemon athletica
LULU
|
$938M |
| 3 |
West Pharmaceutical
WST
|
$51.3M |
| 4 |
NTUS
Natus Medical Inc
NTUS
|
$10.5M |
| 5 |
Topgolf Callaway Brands
MODG
|
$7.65M |
Sector Composition
| 1 | Technology | 31.8% |
| 2 | Healthcare | 25.3% |
| 3 | Consumer Discretionary | 16.67% |
| 4 | Industrials | 10.42% |
| 5 | Financials | 10.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
AtriCure
ATRC
$1.84B
| $6.18M | 0.02% | 154,839 +3,994 | +3% | +$159K |
|
|
CCF
127
DELISTED
Chase Corporation
CCF
| $5.99M | 0.02% | 62,742 +10,929 | +21% | +$1.04M |
|
128
Glaukos
GKOS
$5.5B
| $5.87M | 0.02% | 118,594 +7,533 | +7% | +$373K |
|
129
Ultragenyx Pharmaceutical
RARE
$2.89B
| $5.57M | 0.02% | 67,812 +4,166 | +7% | +$342K |
|
130
Mine Safety
MSA
$6.68B
| $5.39M | 0.02% | 40,180 +2,271 | +6% | +$305K |
|
|
MYOK
131
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.18M | 0.02% | 38,019 +2,259 | +6% | +$308K |
|
132
Axsome Therapeutics
AXSM
$6.05B
| $5.12M | 0.02% | 71,910 +25,905 | +56% | +$1.85M |
|
|
GAN
133
DELISTED
GAN Ltd
GAN
| $5.01M | 0.02% | 296,165 +22,040 | +8% | +$372K |
|
134
Fate Therapeutics
FATE
$120M
| $5M | 0.02% | 125,188 +7,461 | +6% | +$298K |
|
135
Insmed
INSM
$28.8B
| $5M | 0.02% | 155,580 +9,309 | +6% | +$299K |
|
136
Wingstop
WING
$9.16B
| $4.66M | 0.02% | 34,086 -17,467 | -34% | -$2.39M |
|
137
Kodiak Sciences
KOD
$478M
| $4.62M | 0.02% | 77,976 +42,318 | +119% | +$2.51M |
|
138
Synopsys
SNPS
$112B
| $4.57M | 0.02% | 21,340 +4,110 | +24% | +$879K |
|
139
Kura Oncology
KURA
$686M
| $4.27M | 0.02% | 139,462 +8,564 | +7% | +$262K |
|
|
BHVN
140
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $4.27M | 0.02% | 65,669 +3,919 | +6% | +$255K |
|
|
CCXI
141
DELISTED
ChemoCentryx, Inc.
CCXI
| $4.06M | 0.01% | +74,108 | New | +$4.06M |
|
|
TRHC
142
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.04M | 0.01% | 99,109 +5,889 | +6% | +$240K |
|
143
BridgeBio Pharma
BBIO
$9.89B
| $3.97M | 0.01% | 105,796 +6,523 | +7% | +$245K |
|
144
Ligand Pharmaceuticals
LGND
$3.15B
| $3.7M | 0.01% | 38,807 +2,424 | +7% | +$231K |
|
145
Halozyme
HALO
$8.56B
| $3.47M | 0.01% | 132,049 -71,771 | -35% | -$1.89M |
|
146
Regis Corp
RGS
$54M
| $3.38M | 0.01% | 549,636 +13,435 | +3% | +$82.5K |
|
147
Amazon
AMZN
$2.44T
| $3.34M | 0.01% | 1,062 | – | – |
|
148
Simulations Plus
SLP
$285M
| $3.18M | 0.01% | 42,218 | – | – |
|
|
TPTX
149
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $3.09M | 0.01% | 35,340 +2,268 | +7% | +$198K |
|
150
Acadia Pharmaceuticals
ACAD
$4.38B
| $3.02M | 0.01% | 73,119 +3,349 | +5% | +$138K |
|